The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000152.5(GAA):c.2510G>A (p.Arg837His)

CA8815778

284232 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: fbe6b9cc-48c6-4253-b120-123974da4a50
Approved on: 2023-10-08
Published on: 2024-02-11

HGVS expressions

NM_000152.5:c.2510G>A
NM_000152.5(GAA):c.2510G>A (p.Arg837His)
NC_000017.11:g.80118221G>A
CM000679.2:g.80118221G>A
NC_000017.10:g.78092020G>A
CM000679.1:g.78092020G>A
NC_000017.9:g.75706615G>A
NG_009822.1:g.21666G>A
ENST00000302262.8:c.2510G>A
ENST00000302262.7:c.2510G>A
ENST00000390015.7:c.2510G>A
ENST00000573556.1:n.463G>A
NM_000152.3:c.2510G>A
NM_001079803.1:c.2510G>A
NM_001079804.1:c.2510G>A
NM_000152.4:c.2510G>A
NM_001079803.2:c.2510G>A
NM_001079804.2:c.2510G>A
NM_001079803.3:c.2510G>A
NM_001079804.3:c.2510G>A

Uncertain Significance

Met criteria codes 2
PM2_Supporting PP3
Not Met criteria codes 2
PP4 PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Lysosomal Storage Disorders Variant Curation Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
The NM_000152.5:c.2510G>A variant in GAA is a missense variant predicted to cause substitution of Arginine by Histidine at amino acid 837 (p.Arg837His). The highest population minor allele frequency in gnomAD v2.1.1 is 0.00019 (3/16178 alleles) in the African population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting). The computational predictor REVEL gives a score of 0.845 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3). This variant has been detected in at least 3 individuals, but not with a pathogenic or likely pathogenic variant. Also, no symptoms of Pompe disease were described for any of the individuals (PMID: 27711114, internal laboratory data). Therefore, this does not meet PM3 or PP4. There is a ClinVar entry for this variant (Variation ID: 284232, 2 star review status) with 6 submitters classifying the variant as a variant of uncertain significance. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for Pompe disease based on the ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert panel (specifications Version 2.0): PM2_Supporting, PP3. (Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on October 8, 2023).
Met criteria codes
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00019 (3/16178 alleles) in the African population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.001), meeting this criterion (PM2_Supporting).
PP3
The computational predictor REVEL gives a score of 0.845 which is above the threshold of 0.7, evidence that correlates with impact to GAA function (PP3).
Not Met criteria codes
PP4
No patients with this variant have documented GAA deficiency and therefore PP4 is not met.
PM3
This variant has been detected in at least 3 individuals (PMID: 27711114, internal laboratory data), but not with a pathogenic or likely pathogenic variant. Therefore, this does not meet PM3.
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.